These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 513949)

  • 21. Enzyme-induced inactivation of transminases by acetylenic and vinyl analogues of 4-aminobutyrate.
    John RA; Jones ED; Fowler LJ
    Biochem J; 1979 Feb; 177(2):721-8. PubMed ID: 435262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The pharmacology of GABA-transaminase inhibitors.
    Palfreyman MG; Schechter PJ; Buckett WR; Tell GP; Koch-Weser J
    Biochem Pharmacol; 1981 Apr; 30(8):817-24. PubMed ID: 6113832
    [No Abstract]   [Full Text] [Related]  

  • 23. Blockade of methamphetamine-induced depression of tyrosine hydroxylase by GABA transaminase inhibitors.
    Hotchkiss A; Gibb JW
    Eur J Pharmacol; 1980 Aug; 66(2-3):201-5. PubMed ID: 6108224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical blockade of a muscimol response by THIP, a GABA agonist and also by GABA-transaminase inhibitors.
    Menon MK
    Neuropharmacology; 1981 Dec; 20(12A):1183-6. PubMed ID: 7322293
    [No Abstract]   [Full Text] [Related]  

  • 25. Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors.
    Schechter PJ; Tranier Y; Jung MJ; Böhlen P
    Eur J Pharmacol; 1977 Oct; 45(4):319-28. PubMed ID: 923642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of gamma-vinyl GABA on bicuculline-induced seizures.
    Kendall DA; Fox DA; Enna SJ
    Neuropharmacology; 1981 Apr; 20(4):351-5. PubMed ID: 7290349
    [No Abstract]   [Full Text] [Related]  

  • 27. Catalytic inhibition of gamma-aminobutyric acid - alpha-ketoglutarate transaminase of bacterial origin by 4-aminohex-5-ynoic acid, a substrate analog.
    Jung MJ; Metcalf BW
    Biochem Biophys Res Commun; 1975 Nov; 67(1):301-6. PubMed ID: 1201024
    [No Abstract]   [Full Text] [Related]  

  • 28. Does homocarnosine mediate the dyskinetic movements induced by gaba-transaminase inhibitors.
    Robin MM; Palfreyman MG
    Neuropharmacology; 1982 May; 21(5):479-82. PubMed ID: 7110536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of gabaculine, a new potent inhibitor of gamma-amonobutyrate transaminase, on the brain gamma-amonobutyrate content and convulsions in mice.
    Matsui Y; Deguchi T
    Life Sci; 1977 Apr; 20(7):1291-5. PubMed ID: 850479
    [No Abstract]   [Full Text] [Related]  

  • 30. A novel inhibitor of gamma-aminobutyrate aminotransferase with anorectic activity.
    White HL; Howard JL; Cooper BR; Soroko FE; McDermed JD; Ingold KJ; Maxwell RA
    J Neurochem; 1982 Jul; 39(1):271-3. PubMed ID: 7086415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Irreversible inhibitors of GABA transaminase induce antinociceptive effects and potentiate morphine.
    Buckett WR
    Neuropharmacology; 1980 Aug; 19(8):715-22. PubMed ID: 7191489
    [No Abstract]   [Full Text] [Related]  

  • 32. Di-n-propylacetate and GABA degradation. Preferential inhibition of succinic semialdehyde dehydrogenase and indirect inhibition of GABA-transaminase.
    van der Laan JW; de Boer T; Bruinvels J
    J Neurochem; 1979 Jun; 32(6):1769-80. PubMed ID: 376783
    [No Abstract]   [Full Text] [Related]  

  • 33. Increased CSF gamma-aminobutyric acid after treatment with gamma-vinyl GABA.
    Grove J; Tell G; Schechter PJ; Koch-Weser J; Warter JM; Marescaux C; Rumbach L
    Lancet; 1980 Sep; 2(8195 pt 1):647. PubMed ID: 6107437
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of gamma-vinyl GABA alone or associated with diazepam on a conflict test in the rat.
    Huot S; Robin M; Palfreyman MG
    Adv Biochem Psychopharmacol; 1981; 29():45-52. PubMed ID: 7257938
    [No Abstract]   [Full Text] [Related]  

  • 35. Inhibitors of GABA metabolism: implications for Huntington's disease.
    Schwarcz R; Bennett JP; Coyle JT
    Ann Neurol; 1977 Oct; 2(4):299-303. PubMed ID: 152600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular effects of GABA, GABA-aminotransferase inhibitors and valproic acid following systemic administration in rats, cats and dogs: pharmacological approach to localize the site of action.
    Löscher W
    Arch Int Pharmacodyn Ther; 1982 May; 257(1):32-58. PubMed ID: 6810779
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Effect of an irreversible inhibitor (RMI71645) of gamma-aminobutyric acid (GABA) transaminase on spontaneous and conditioned activities of mice].
    Misslin R; Hinschberger A; Ropartz P; Mandel P
    C R Acad Hebd Seances Acad Sci D; 1976 Oct; 283(10):1221-4. PubMed ID: 827360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proceedings: Comparison of circling behaviour following unilateral inhibition of GABA-transaminase or discrete electroyltic lesioning in the rat substantia nigra.
    Dray A; Fowler LJ; Oakley NR; Simmonds MA; Tanner T
    Br J Pharmacol; 1975 Oct; 55(2):288P. PubMed ID: 1238134
    [No Abstract]   [Full Text] [Related]  

  • 39. Systemic and in vitro effects of GAD and GABA-T inhibitors on AADC activity and of AADC inhibitors on GAD.
    Giorgi O; Rubio MC
    Gen Pharmacol; 1981; 12(4):217-23. PubMed ID: 7250670
    [No Abstract]   [Full Text] [Related]  

  • 40. The inhibition by substrate analogues of gamma-aminobutyrate aminotransferase from mitochondria of different subcellular fractions of rat brain.
    Tunnicliff G; Ngo TT; Rojo-Ortega JM; Barbeau A
    Can J Biochem; 1977 Apr; 55(4):479-84. PubMed ID: 870153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.